438
podcast episode
Ep. 16: The Translator, with PCF’s Jonathan Simons
“This is why we all went into medicine—for moments like this where we come together.”
podcast episode
Ep. 21: Ramping Up, with Novartis’s Vasant Narasimhan
“Our thinking is, how do we create a protease inhibitor that could work on future coronaviruses, n
ot just the current coronavirus?...Fundamentally, our ability to withstand pandemics is likely going to center around our ability to think of this
+ Read More
podcast episode
Ep. 119: Revolutionary, with UC Berkeley's Jennifer Doudna
“Diagnosis goes hand in hand with vaccination, and of course with therapies as well. What CRISPR i
s doing is providing for rapid turnaround testing at a lower cost and higher throughput than we've had with other technologies.
+ Read More
podcast episode
Ep. 115: New Heroes, with NIH's Francis Collins
“It has been a year of terrible tragedy. … And yet, it's also been a year of heroism: the first re
sponders, the healthcare providers, putting themselves at risk to try to help those who are suffering.
+ Read More
podcast episode
Ep. 111: Global Scale, with Leaders from Murdoch Children’s Research Institute
“With COVID, there's been this renewed focus on the importance of medical research...With more fun
ding and with philanthropic partners, I'm really optimistic about the further impact that we can make on that global scale.” - Sarah Murdoch, of th
+ Read More
podcast episode
Ep. 113: "To Boldly Go," with Operation Warp Speed's Moncef Slaoui
“The efficacy of these vaccines is spectacular. It's 95%, the same whether you are an African-Amer
ican or Hispanic or over 65 years old.
+ Read More
podcast episode
Ep. 112: Speed of Science, with Pfizer’s Albert Bourla and Johnson & Johnson’s Alex Gorsky
“I think history has shown us to have major leaps forward almost after every crisis.
podcast episode
Ep. 109: Lessons Learned: the Intersection of Cancer Research and COVID Treatments
“The road to curing COVID runs right through lots and lots of cancer research.” - Jonathan Simons,
President and CEO, Prostate Cancer Foundation
+ Read More
podcast episode
Ep. 106: On the Verge: Leaders in Bioscience Discuss the State of Vaccines and Treatments
“We're going to need vaccines to create as widespread herd immunity as we can, but we're also goin
g to need drugs that are targeted against the virus that can provide immediate protection and also treat those who are already sick," says Regenero
+ Read More
podcast episode
Ep. 96: Transitions, with the Peter MacCallum Cancer Centre’s Michael Hofman
“Once you have a whole body PET scan, there's not a lot of value often in doing a physical examina
tion or taking out your stethoscope because the information on that scan tells you everything you need to know.
+ Read More
podcast episode
Ep. 54: In Translation, with NCATS’ Christopher Austin
“Are we going to require the same level of evidence for a vaccine...before it is approved? Could w
e potentially begin to use it at the same time we're still studying it?
+ Read More